IHC-IDH 1 Antibody Test, Price, Normal Range | Sprint Diagnostics Hyderabad

No fasting is required before this test. It's essential to inform your healthcare provider about any medications you're taking as they could potentially affect the procedure or results.

This test is typically ordered when there's a clinical suspicion or confirmed diagnosis of a brain tumor. Your healthcare provider will recommend when this test should be done based on your symptoms and medical history.

This test measures the presence of a mutated IDH1 enzyme in tissue samples, which can be a marker for certain types of brain tumors.

The frequency of this test is based on your healthcare provider's recommendation. It's usually performed when there's a need to diagnose or monitor the progression of brain tumors, or to inform treatment decisions.

This test typically yields qualitative results, indicating either the presence or absence of the IDH1 mutation. Your healthcare provider will discuss what your specific results mean in the context of your overall health and condition.

No special precautions are needed for this test. However, it's always advisable to share any concerns or queries you may have with your healthcare provider.

IDH1 levels can be influenced by various factors. Some nonmodifiable factors include genetics and certain diseases like brain tumors. Modifiable factors could potentially include certain treatments and medications.

Abnormal test results should be discussed with a healthcare provider, typically a neuro-oncologist, who is experienced in treating brain tumors.

Always inform your healthcare provider about any medications you're taking. Some drugs might interfere with the test results or the procedure used to collect the tissue sample.

The test itself doesn't cause pain. However, the tissue sample collection process, which often involves a biopsy, might cause some discomfort. Your healthcare provider will take all necessary steps to minimize discomfort and ensure the procedure is as painless as possible.

Follow your healthcare provider's instructions regarding wound care and follow-up appointments. If you experience any unexpected side effects or complications, immediately seek medical help.

Yes, the IHC-IDH 1 antibody test is an accurate method for detecting IDH1 mutations in tissue samples. However, like any test, it should be interpreted in the context of other clinical information and diagnostic findings.

The turnaround time for this test generally varies from 7 to 10 days, depending on the laboratory and specific conditions.

Yes, this test can be performed on patients of any age if the healthcare provider considers it necessary. It's important to discuss any concerns about the test with your child's healthcare provider.

In conclusion, the IHC-IDH 1 antibody diagnostic test is a vital tool in the hands of healthcare providers, assisting them in making informed decisions about your health management plan. The complexity of the test shouldn't discourage you; the information it provides contributes significantly to personalized treatment strategies, ultimately aiming for the best possible outcome in disease management. Remember, this test should be considered as part of a wider diagnostic approach, and results should always be interpreted alongside other clinical findings.